Contact Us






Latest News



Current Articles | RSS Feed RSS Feed

Preventice and eCardio Diagnostics Announce Strategic Combination in Cardiac Patient Monitoring Market


MINNEAPOLIS and HOUSTON – September 9, 2014 – Preventice, developer of the PatientCare™ Platform and the BodyGuardian® Remote Monitoring Sensor and an innovator in software solutions for remote patient care, and eCardio Diagnostics® LLC, a leading provider of remote cardiac monitoring products and services, announced today a strategic combination of Preventice and eCardio to drive innovation and growth in remote monitoring systems and mobile health applications. The two companies will now operate as wholly-owned subsidiaries of a newly formed holding company, Preventice, Inc.

Preventice adds three-in-one switchability to BodyGuardian® Sensor


MINNEAPOLIS (August 25, 2014)Preventice®, Inc., announced today improvements to its BodyGuardian® Remote Monitoring System (BodyGuardian) that have the potential to simplify the remote monitoring experience for patients and contribute to a more efficient care delivery process when transitioning between monitoring needs for individual patients. At the same time, the improved BodyGuardian could simplify administrative billing and service operations for health care providers. The BodyGuardian product enhancements make these improvements possible by combining three essential monitoring technologies—mobile cardiac telemetry, event monitoring and Holter monitoring—in one easy-to-use device.

Preventice® hires Kevin Nickels as chief operating officer


MINNEAPOLIS (October 29, 2013) - Preventice®, Inc. announced today that Kevin Nickels has joined the company as chief operating officer. Nickels brings nearly 40 years experience in product and business development; general management; and an ability to raise and monetize invested capital —26 of which were spent at medical device companies—to his new role at Preventice. He will be responsible for leading the global market expansion of the BodyGuardian® Remote Monitoring System (BodyGuardian) and for continuing to evolve and enhance operations for the company’s remote monitoring solutions.

Preventice, Inc. enhances arrhythmia classification capabilities of its BodyGuardian Remote Monitoring System

describe the image

MINNEAPOLIS (Oct. 17, 2013)Preventice®, Inc., announced today it has enhanced the ability of its BodyGuardian® Remote Monitoring System (BodyGuardian) to identify anomalous ECG rhythms and will now provide greater precision in identifying the type of arrhythmias that occurred when reporting events to care teams. The new capability supports the clinical scalability of BodyGuardian by increasing clinician efficiency as identified events are reviewed to confirm arrhythmia classifications.

Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System


European clinical trial interest remains strong; company poised for global distribution

(October 9, 2013)Preventice®, Inc., announced today that it has received CE Mark certification for its BodyGuardian® Remote Monitoring System from the European Commission.

Developed in collaboration with Mayo Clinic, the BodyGuardian uses sophisticated algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian allows physicians to monitor key biometrics outside the clinical setting, while patients go about their daily lives. A small body sensor attached to the patient’s chest collects important data, including the patient’s ECG, heart rate, respiration rate and activity level. Patient data can then be transmitted to physicians via mobile phone technology. Remote patient monitoring can create a constant connection between patients and their care teams.

Preventice, Inc. appoints medical advisory board


Healthcare industry leaders to provide clinical guidance for ongoing evolution of BodyGuardian Remote Monitoring System and remote monitoring capabilities

(October 3, 2013) Preventice®, Inc., a leader in remote patient monitoring technology, announced today the appointment of a medical advisory board. The company tapped recognized leaders in clinical cardiology, patient monitoring technology, health sciences and nursing to guide the evolution of remote monitoring solutions, including the BodyGuardian® Remote Monitoring System, and to provide insight into the clinical needs of physicians, patients and life sciences companies.

“Preventice and the BodyGuardian are grounded in a mission to meet real-life clinical needs. Remote monitoring systems like BodyGuardian address the desire for technology that improves outcomes and saves money, without interrupting a patient’s normal daily activities or affecting their quality of life,” said Jon Otterstatter, co-founder, president and CEO of Preventice. “The medical advisory board will keep Preventice in touch with the changing needs of the professionals who prescribe and use the BodyGuardian, and the patients who benefit from this technology.”

Preventice®, Inc. receives ISO 13485: 2003 certification

Preventice® announces BodyGuardian receives ISO certification

MINNEAPOLIS (Sept. 3, 2013)Preventice®, Inc., which produces the BodyGuardian® Remote Monitoring System (BodyGuardian RMS), announced today that it has received ISO 13485: 2003 certification.

Preventice® executive, Michael Emerson, to present at Wearable Technologies Conference 2013


MINNEAPOLIS (July 15, 2013) Michael Emerson, senior vice president of marketing for Preventice, will discuss the game-changing potential of remote monitoring technology and the BodyGuardian RMS during a presentation titled, “Connected Care Everywhere: Wearable Technologies,” at the Wearable Technologies Conference 2013. Emerson’s presentation will take place Tuesday, July 23 at 9:45 a.m., PT, at the Fort Mason Center in San Francisco, Calif.

Preventice® announces commercial availability of BodyGuardian Remote Patient Monitoring System™


Multiple clinical trials and pilot programs underscore growing interest in wireless patient monitoring technology

Preventice to demonstrate BodyGuardian Remote Patient Monitoring System at ACC.13


 MINNEAPOLIS (February 27, 2013) Preventice, Inc. announced today that it will participate in the ACC.13, hosted by the American College of Cardiology on March 9-11, 2013 in San Francisco. ACC.13 is expected to attract more than 300 companies and organizations showcasing the latest advances in pharmaceuticals, imaging, devices, health IT, and services needed to treat cardiac patients. Preventice, a leading developer of mobile health solutions, will be on hand to showcase its breakthrough mobile health solutions for remote patient monitoringpatient education and patient engagement technologies.

All Posts